Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of <it>Streptococcus pneumoniae </it>by clinical laboratories in the United States during 2002 and 2003

<p>Abstract</p> <p>Background</p> <p>The Performance Standards for Antimicrobial Susceptibility Testing, Twelfth Informational Supplement, M100-S12, published by the National Committee for Clinical Laboratory Standards (NCCLS) in January 2002 introduced distinct minimum inhibitory concentration (MIC...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Thornsberry Clyde, Jones Mark E, Draghi Deborah C, Master Ronald N, Sahm Daniel F, Karlowsky James A
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2004-01-01
Reeks:	Annals of Clinical Microbiology and Antimicrobials
Online toegang:	http://www.ann-clinmicrob.com/content/3/1/1
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!